Top Markets
Coin of the day
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Rang în acțiuni #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Preț acțiune
$0.05207079
Ultima sincronizare: 2023-11-15
Capitalizare de piață
$3.38M
Schimbare (1 zi)
0.13%
Schimbare (1 an)
0.00%
Țară
AU
Tranzacționează Kazia Therapeutics Limited (KZA)

Categorie

Istoricul spliturilor pentru Kazia Therapeutics Limited (KZA)
Acțiunea Kazia Therapeutics Limited (simbol: KZA) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 16, 2026.
O acțiune KZA cumpărată înainte de Aug 16, 2026 este echivalentă astăzi cu 0 acțiuni KZA.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE